A Multidisciplinary Approach to Primary Immunodeficiency
Statement of Need
Primary immunodeficiency disorders (PIDs) are a group of genetic disorders that affect development and function in the immune system. PIDs can leave patients vulnerable to frequent, severe, and unusual infections, and are associated with significant morbidity; patients with PIDs are twice as likely to be hospitalized and have significantly longer hospital stays.
Timely diagnosis and early treatment interventions are critically important to mitigate the disease and economic burden of PID, but the management of PID can be challenging for clinicians due to its complexity. Human immune globulin (Ig) therapy has significantly improved life expectancy and quality of life (QoL) for patients with PID; however, selecting a therapeutic product can be a complex choice, as it requires a thorough understanding of the classification of PIDs and the appropriate matching of a personalized treatment based on patient-specific factors.
This CME Outfitters On Demand webcast is a case-based activity featuring expert faculty addressing the diagnosis and management of PIDs, as well as strategies for raising PID awareness and education.
Target Audience
Primary care physicians, pediatricians, specialists, infusion nurses, pharmacists, nurse practitioners, and physician assistants.
Learning Objectives
At the end of this CE activity, participants should be able to:
- Identify signs and symptoms of primary immunodeficiency to decrease diagnostic delays.
- Implement evidence-based treatment strategies to manage PID.
- Educate and inform patients about PID to reduce morbidity and improve quality of life (QoL).
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Identify signs and symptoms of primary immunodeficiency to decrease diagnostic delays.
- Discuss evidence-based treatment strategies to manage PID.
- Describe ways to educate and inform patients about PID to reduce morbidity and improve quality of life (QoL).
Additional Information
Mark Ballow, MD (Moderator)
Professor, Department of Pediatrics
University of South Florida, Morsani College of Medicine
Division of Allergy & Immunology
Johns Hopkins All Children's Hospital
St. Petersburg, FL
Dr. Ballow reports that he is on the advisory committee for CSL Behring; and Takeda Pharmaceuticals U.S.A., Inc. He is a consultant for Grifols. He is on the speaker’s bureau for CSL Behring and Takeda Pharmaceuticals U.S.A., Inc.
Kristin Epland, MSN, FNP-C
Family Nurse Practitioner
Midwest Immunology Clinic
Plymouth, MN
Ms. Epland reports that she serves on the advisory committee for IDF Nurse Advisory Committee; Pharming Group NV and Takeda Pharmaceuticals, Inc. U.S.A. (Immunoglobulin Nurse Advisor). She serves as a consultant for the Takeda Pharmaceuticals, Inc. U.S.A speaker program.
Niraj C. Patel, MD, MS
Chief, Pediatric Infectious Disease and Immunology
Director, Charlotte Immunodeficiency Center
Adjunct Associate Professor, University of North Carolina
Levine Children's Hospital, Atrium Health
Charlotte, NC
Dr. Patel reports that he received research support from CSL Behring and Takeda. He is on the advisory committee for Baxalta Inc. and Horizon Therapeutics. he is on the speaker’s bureau for CSL Behring; Horizon Therapeutics and Takeda Pharmaceuticals U.S.A., Inc.
Conflict of Interest Disclosure Policy
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Disclosure of Unlabeled Use
CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
This educational initiative is provided by CME Outfitters.
AMA PRA Category 1 Credit TM
Accreditation Statement
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
CME Outfitters, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 Credit TM/ ABIM MOC Points
Accreditation Statement
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
CME Outfitters, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Part II Points:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
CNE Contact Hour(s)
Accreditation Statement
CME Outfitters, LLC, is approved by the California Board of Registered Nursing.
Designation Statement
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.
CE for Pharmacists
Accreditation Statement
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number: Enduring: 0376-0000-20-006-H01-P
Type: Knowledge-based
MIPS Improvement Activity
This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Accredited Provider Disclosure
The CME Outfitters, LLC staff has no disclosures to report
Available Credit
- 1.50 MOC
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
This course is offered through MyCME. To take this course you will be redirected to MyCME's website. You must have an account with MyCME in order to complete this activity.
MOCINGBIRD continues to work with our CME partner network to provide courses directly to you. We appreciate your patience as we work toward that goal!